GSK deal with generics may ‘abuse’ EU competition laws
Agreements between patent holders and generic manufactures to not enter a specific market may break EU competition law, a
Court of Justice for the European Union (CJEU) advocate general has opined.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.